Emerging and Investigational JAK Inhibitors for Rheumatoid Arthritis: Efficacy and Safety. [PDF]
Costa L +4 more
europepmc +1 more source
Computational Repurposing of Janus Kinase Inhibitors as Potential Therapeutic Candidates for Alzheimer's Disease. [PDF]
Nguyen LTH, Nguyen MT, Nguyen TU.
europepmc +1 more source
Targeted Nanoparticles for PROTAC-Mediated JAK1/JAK2 Degradation for Bladder Cancer Treatment. [PDF]
Ding W +6 more
europepmc +1 more source
Advanced Biological Therapies: Principles, Mechanisms and Medical Applications. [PDF]
Brozek R +3 more
europepmc +1 more source
Comparative Risk of Serious Infections with Biologic Agents and Oral Small Molecules in Inflammatory Bowel Diseases: 2026 Update. [PDF]
Solitano V +6 more
europepmc +1 more source
Therapeutic expansion of JAK inhibitors in Chinese dermatological practice: beyond atopic dermatitis to novel autoimmune frontiers. [PDF]
Lyu X +5 more
europepmc +1 more source
Differential regulation of SOCS signalling and immunoproteasome pathways by JAK inhibitors and TNF inhibitors in rheumatoid arthritis. [PDF]
Ghannam K +10 more
europepmc +1 more source
Emerging CCR5-Based Therapeutic Potential of JAK/STAT Inhibitors and CCR5Δ32 Hematopoietic Stem Cell Transplantation. [PDF]
Khalid K +6 more
europepmc +1 more source
T Cell-Derived IFN-γ Activates Ferroptosis in Lacrimal Luminal Ductal Cells via JAK-STAT Signaling in Sjögren's Disease-Related Dry Eye. [PDF]
Wang B +9 more
europepmc +1 more source

